Carospir
Payments companies reported to CMS as associated with Carospir. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Carospir, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Carospir
These are the largest totals companies reported as associated with Carospir. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Larry Neuman | New York, NY | Internal Medicine | $6,162.34 |
| John Lai | Daly City, CA | Internal Medicine | $596.49 |
| Kevin Wong | Daly City, CA | Internal Medicine | $535.92 |
| Richard Khalil | Yonkers, NY | Family Medicine | $436.07 |
| Shashwati Kale | San Jose, CA | Family Medicine | $394.47 |
| Donald Siao | San Jose, CA | Family Medicine | $242.26 |
| Bina Raghavan | San Jose, CA | Medical | $227.92 |
| Navdeep Bamrah | San Jose, CA | Family | $219.91 |
| Shannon Donovan | Nashville, TN | Family | $200.00 |
| Susan Hoffman | Palo Alto, CA | Internal Medicine | $188.05 |
Prescribed Carospir?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.